CTS (CTS) Earnings Date & Reports

Key Takeaways

• CTS Corporation reported third-quarter 2026 sales of $149.6 million, up 5% year over year and above consensus estimates of roughly $145.9 million.
• Adjusted diluted earnings per share (EPS) reached a record $0.77, up from $0.60 a year earlier and well ahead of the consensus estimate of approximately $0.65.
• Adjusted gross margin climbed to a record 42.2%, up 330 basis points versus the prior-year quarter, while adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) margin rose to 24.7%.
• Management raised full-year 2026 guidance to sales of $580 million to $590 million and adjusted diluted EPS of $2.78 to $2.88.
• The recently completed acquisition of Millar advances the company's diversification strategy, particularly in the medical end market.
• For more detail on CTS, explore Major News, Today's Price Move, Price Targets, and Forecast on Tickeron's dedicated pages.
• Discover related opportunities by exploring Trending AI Robots.

Earnings Context and Why It Matters

CTS Corporation, a designer and manufacturer of electronic components and sensors serving original equipment manufacturers (OEMs), has been steadily shifting its revenue mix toward faster-growing diversified end markets. The third quarter of 2026 offered investors a fresh read on that strategy, as medical, aerospace and defense, and industrial segments increasingly complement the company's traditional transportation business. With transportation tied to softer global light-vehicle production, execution in diversified markets and margin discipline have become central to the investment thesis. This report also carried added weight because it followed the announcement of the Millar acquisition, a deal that expands CTS's presence in medical sensing and reshapes its long-term growth profile.

Reported Results

For the third quarter ended September 30, 2026, CTS posted sales of $149.6 million, a 5% increase from $143.0 million in the prior-year period and about 2.5% above consensus estimates near $145.9 million. Diversified end-market sales rose 7% year over year and represented 60% of total revenue, while transportation sales grew 2%.

Net earnings were $17.8 million, up from $13.7 million a year earlier, with GAAP (Generally Accepted Accounting Principles) diluted EPS of $0.61 versus $0.46 in the year-ago quarter. On an adjusted basis, which excludes non-recurring items, diluted EPS reached a record $0.77, up from $0.60 and comfortably above the consensus of roughly $0.65.

Profitability improved meaningfully. Adjusted gross margin hit a record 42.2%, up 330 basis points year over year, and adjusted EBITDA margin expanded about 90 basis points to 24.7%. Operating cash flow reached $44 million in the quarter, supporting a strong balance sheet. Management also raised full-year 2026 guidance, now expecting sales of $580 million to $590 million and adjusted diluted EPS of $2.78 to $2.88.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. By surfacing trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening, the platform is designed to save time and sharpen decision-making. For those tracking names like CTS, the AI Screener offers a practical way to monitor shifting technical and fundamental conditions across the market.

Market Reaction and Investor Sentiment

Shares of CTS jumped in morning trading on October 27, 2026, following the release, with reports indicating a rise of roughly 4.5% as investors responded to results that topped estimates and an upwardly revised full-year outlook. The stock had already gained about 25.8% year to date, outpacing the broader S&P 500, reflecting improving sentiment around the company's diversification progress and margin expansion.

Investor interpretation centered on the durability of growth in diversified end markets and the record profitability. The beat on both revenue and adjusted EPS, combined with raised guidance, signaled stronger-than-expected operational execution. At the same time, attention remained on the more modest transportation growth and management's caution around tariffs, geopolitical uncertainty, and a normalization of profitability in coming quarters.

Forward Outlook and Key Factors to Monitor

Looking ahead, CTS's raised full-year guidance implies continued momentum into the fourth quarter, supported by a healthy order backlog in aerospace and defense and resilient demand in industrial and medical markets. The company's book-to-bill ratio of 1.18 for the third quarter, with a notably strong 1.9 reading in aerospace and defense, suggests sustained customer demand heading into 2027.

The Millar acquisition will be a central watch item. Expected to contribute roughly $30 million in annual revenue and to become accretive to earnings in the second half of 2027, the deal deepens CTS's exposure to medical and industrial sensing. Investors will monitor integration progress and whether the transaction delivers the anticipated margin and diversification benefits.

Key risk factors include tariff changes, metals and oil inflation, and potential softness in global light-vehicle production. Management has also flagged that record profitability may normalize in the near term as favorable end-market mix and foreign-exchange benefits ease. How CTS sustains margins while absorbing Millar and navigating cost pressures will likely shape sentiment in the quarters ahead.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations